Compare Agilent Technologies Inc (A) vs Rivian Automotive, Inc. (RIVN) Price & Performance

Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.

The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.

Rivian Automotive (RIVN) trades at $16.00, up 4.03% today, with a bullish technical signal and support at $15–16. The company reported Q2 2026 EPS of -$0.47, beating estimates, and raised 2026 delivery guidance to 65,000–70,000 vehicles. Revenue grew to $5.39B in 2025, but net losses persist at -$3.65B, with cash flow negative. Analyst consensus is mixed, with a $18.70 price target and 48% buy ratings.

Outlook hinges on R2 SUV ramp-up and cost controls, with potential for margin improvement by late 2026. Key risks include high cash burn, execution delays, and EV market competition. Upside exists if profitability targets are met, but investors face volatility amid funding needs and sector headwinds.